Cite
HARVARD Citation
Cattel, F. et al. (2015). Economic impact of antifungal treatment in IFD by Candida species: anidulafungin administration as a cost-effective alternative for critical care patients. European journal of hospital pharmacy. 22 (1), pp. 12-17. [Online].